These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4180869)

  • 1. Cyclophosphamide in multiple sclerosis.
    Millac P; Miller H
    Lancet; 1969 Apr; 1(7598):783. PubMed ID: 4180869
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of cyclophosphamide to treat multiple sclerosis.
    Myers LW
    Clin Neuropharmacol; 1987 Apr; 10(2):155-61. PubMed ID: 3332608
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of cyclophosphamide in the treatment of multiple sclerosis.
    Weiner HL; Hauser SL; Hafler DA; Fallis RJ; Lehrich JR; Dawson DM
    Ann N Y Acad Sci; 1984; 436():373-81. PubMed ID: 6099707
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].
    Pette M; Hartung HP; Toyka KV
    Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive treatment of multiple sclerosis.
    Schweitzer SF
    J Neurosurg Nurs; 1985 Aug; 17(4):256-9. PubMed ID: 2993548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term intensive cyclophosphamide treatment in progressive multiple sclerosis.
    Siracusa GF; Amato MP; Fratiglioni L; Sità D; Amaducci L
    Ital J Neurol Sci; 1987 Dec; 8(6):589-92. PubMed ID: 3429217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamide.
    Yeh EA; Weinstock-Guttman B
    Neurology; 2009 Jun; 72(24):2064-5. PubMed ID: 19439721
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis.
    Killian JM; Bressler RB; Armstrong RM; Huston DP
    Arch Neurol; 1988 Jan; 45(1):27-30. PubMed ID: 3276298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide in chronic progressive multiple sclerosis.
    Wenala M
    NITA; 1987; 10(3):219-23. PubMed ID: 3037447
    [No Abstract]   [Full Text] [Related]  

  • 10. Conditioning of cyclophosphamide-induced leukopenia in humans.
    Giang DW; Goodman AD; Schiffer RB; Mattson DH; Petrie M; Cohen N; Ader R
    J Neuropsychiatry Clin Neurosci; 1996; 8(2):194-201. PubMed ID: 9081556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects].
    Kornhuber HH; Mauch E
    Dtsch Med Wochenschr; 1986 Nov; 111(46):1778. PubMed ID: 3780443
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide therapy for MS.
    Gauthier SA; Weiner HL
    Int MS J; 2005 Aug; 12(2):52-8. PubMed ID: 16417815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DIAS rounds. Cyclophosphamide in multiple sclerosis.
    Mason G; Hart LL
    Drug Intell Clin Pharm; 1984 Mar; 18(3):215-6. PubMed ID: 6697883
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.
    Drachman DA; Paterson PY; Schmidt RT; Spehlmann RF
    J Neurol Neurosurg Psychiatry; 1975 Jun; 38(6):592-7. PubMed ID: 1097604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of immunosuppressive agents and particularly of cyclophosphamide on lymphocytes subsets in treated multiple sclerosis patients.
    Gonsette RE; Defalque A; Demonty L
    Riv Neurol; 1987; 57(3):181-4. PubMed ID: 2960008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing care of the multiple sclerosis patient treated with cyclophosphamide.
    Cook CV; Bass BH
    Can Nurse; 1985 Mar; 81(3):36-8. PubMed ID: 3844322
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-lasting effects of cyclophosphamide on lymphocytes in peripheral blood and spinal fluid.
    Uitdehaag BM; Nillesen WM; Hommes OR
    Acta Neurol Scand; 1989 Jan; 79(1):12-7. PubMed ID: 2784607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.
    Steuber CP; Fernbach DJ; Starling KA; Falletta JM
    Cancer Chemother Rep; 1974; 58(3):417-9. PubMed ID: 4601672
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W
    Acta Neurol Belg; 1973; 73(4):209-19. PubMed ID: 4770124
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide levels in serum and spinal fluid of multiple sclerosis patients treated with immunosuppression.
    Hommes OR; Aerts F; Bahr U; Schulten HR
    J Neurol Sci; 1983 Feb; 58(2):297-303. PubMed ID: 6834081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.